Pieris Pharmaceuticals, Inc.

Latest News

View Press Release
View All News

Latest Financial Results

Q3 2024

Quarter Ended Sep 30, 2024
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Report Links

mail icon

Sign Up for Email Alerts

Receive updates straight into your inbox

Sign up today

Company Overview

Pieris is a biotechnology company based in Boston, Massachusetts that could potentially be entitled to receive development, regulatory, and sales-based milestones from its 4-1BB bispecifics immuno-oncology assets partnered with Pfizer (formerly Seagen), Boston Pharmaceuticals, and Servier. In addition to the milestone potential, Pieris would be eligible for sales royalties on the same partnered programs if they ultimately are approved for commercialization. The Company is seeking potential acquirers for its remaining preclinical and clinical assets.

Investor Contact Information

Company

Pieris Pharmaceuticals, Inc.
225 Franklin St., Floor 26
Boston, MA 02110
USA
T: +1-857-246-8998
info@pieris.com

Transfer Agent

Computershare
P.O. Box 43006
Providence RI 02940-3078
T: 1-877-373-6374 (US, Canada, Puerto Rico) or 1-781-575-3100 (non-US)
web.queries@computershare.com
www.computershare.com/investor

Courier Delivery
150 Royall St.
Suite 101
Canton, MA 02021